TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.110
+0.132 (13.44%)
Nov 26, 2025, 4:00 PM EST - Market closed
TScan Therapeutics Employees
As of December 31, 2024, TScan Therapeutics had 195 total employees, including 194 full-time and 1 part-time employees. The number of employees increased by 41 or 26.62% compared to the previous year.
Employees
195
Change (1Y)
41
Growth (1Y)
26.62%
Revenue / Employee
$43,195
Profits / Employee
-$731,272
Market Cap
62.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 195 | 41 | 26.62% |
| Dec 31, 2023 | 154 | 16 | 11.59% |
| Dec 31, 2022 | 138 | 33 | 31.43% |
| Dec 31, 2021 | 105 | 47 | 81.03% |
| Dec 31, 2020 | 58 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TCRX News
- 14 days ago - TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 21 days ago - TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 23 days ago - TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027 - GlobeNewsWire
- 2 months ago - TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025 - GlobeNewsWire
- 3 months ago - TScan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 months ago - TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire